Spindletop Capital Management

What Spindletop Capital Management does

Spindletop Capital Management is a privately held healthcare growth equity firm headquartered in Austin, Texas (3571 Far West Blvd, Suite 108). Founded when its principals were recruited from San Francisco to establish a Texas-based healthcare investor, the firm pursues a Venture Growth Capital strategy focused on commercial-stage, profitable U.S. healthcare companies and provides expansion capital, operational expertise, and board representation to portfolio management teams. It currently operates Fund III and runs a diversified portfolio of eight active investments spanning physician practice management (Sanova Dermatology, Tri City Pain Associates, American Pain Consortium), medical devices and diagnostics (Bioventus, Castle Biosciences), digital health and tech-enabled services (Navigating Cancer, HNI Healthcare), and specialty pharmaceuticals (Edgemont Pharmaceuticals). The firm cites a family office heritage, ILPA-aligned governance, and a "Conscious Capital" impact thesis under which it commits 10% of Fund III GP profits to the Aspen Institute and aligned non-profits.

The firm monetizes through the standard private equity fund model: management fees on committed capital plus carried interest from successful exits, alongside ancillary services to portfolio companies such as diligence support, integration guidance, and public-market access. Distribution is direct, sourced through the firm's Texas institutional ecosystem — Texas Medical Center (52 institutions, 92,000 employees), the $6B CPRIT program (with Dr. Evan Melrose on the selection committee), UT MD Anderson Cancer Center, San Antonio Military Medical Center, NASA, and broader healthcare networks nationally. Target investment structures include minority or majority equity, preferred equity, expansion capital for organic or acquisition-driven growth, and corporate spin-outs, with explicit appetite for roll-ups and consolidations of fragmented healthcare sectors.

The investment team and broader advisor network span clinicians, scientists, operators, and financial professionals aggregating 700+ years of healthcare experience, anchored by Founding Managing Director Dr. Evan Melrose (27 years healthcare experience; prior roles at PTV Sciences and Burrill & Company; Wharton MBA), Managing Director Steve Whitlock (20+ years in orthopaedics), former Goldman Sachs Managing Director Stephen Hipp (in memoriam 1967-2023), ex-PwC Global Healthcare Leader Jim Henry, and operating partner Dr. Robert McDonald (30 years physician leadership). Spindletop's marketed differentiators are family-office permanent capital, Texas resource access, and stakeholder-aligned Conscious Capital — positioning that resonates with limited partners (endowments, family offices, foundations) seeking ILPA-principles adherence and with healthcare entrepreneurs seeking a long-duration partner. Legacy realized exits include IDEV Technologies (sold to Abbott for $310 million) and IPOs/exits via Intersect, Inhibitex, Glycomimetics, Biomimetic, BioForm, and LDR Medical.

Name

Spindletop Capital Management

Legal name

Spindletop Capital

Website

https://spindletopcapital.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Short description

Spindletop Capital Management is a privately held, Austin-based healthcare growth equity firm that provides expansion capital, board representation, and operational expertise to commercial-stage U.S. healthcare companies, currently deploying Fund III across eight diversified portfolio investments with a family-office heritage and ILPA-aligned governance.

Ownership category

akta.pro rank

Product category

Healthcare Private Equity

NAICS

Portfolio Management and Investment Advice (52394), Other Investment Pools and Funds (5259)

SIC

Investment Advice (6282)

akta.pro primary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

akta.pro secondary industry

Transition / Engagement & Stewardship Funds (FSANAJAO)

Keywords

• Healthcare growth equity
• Venture capital management
• Expansion capital
• Healthcare investment services
• Fund management services

Headquarters

HQ city

Austin

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

1. Fund Management: Spindletop Capital operates as a private equity/growth equity fund manager, generating revenue through management fees on committed capital and carried interest (performance fees) from successful portfolio company exits. The firm is currently on Fund III.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Spindletop Capital is a healthcare growth equity firm that provides expansion capital and operational expertise to commercial stage and profitable healthcare companies across the United States. The firm partners with exceptional entrepreneurs and management teams to build transformational healthcare companies through minority or majority investments, preferred equity, and support for organic and acquisition growth. Currently investing through Fund III, the firm generates returns through portfolio company value creation and exits.

Product overview

Spindletop Capital is a purpose-driven healthcare growth equity firm that does not offer a unified software product or platform, but rather provides investment services and manages a portfolio of healthcare companies. Their core offering is expansion capital investment for commercial stage and profitable healthcare companies, diversified across healthcare sectors. The portfolio consists of eight current investments spanning physician practice management (Sanova Dermatology, Tri City Pain Associates, American Pain Consortium), medical devices and diagnostics (Bioventus, Castle Biosciences), digital health (Navigating Cancer, HNI Healthcare), and specialty pharmaceuticals (Edgemont Pharmaceuticals). The firm also maintains a select legacy investments portfolio of previously successful healthcare companies.

Differentiator

Problem solved

Functional benefit

Products and services

• Healthcare Growth Equity Investment Services

Quantifiable outcome

• Target IRR in excess of 30%
• +3 more outcomes

Named customers8 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered core and minor.

• Texas Medical CentercoreStrategic or Co-development PartnerSpindletop Capital leverages the Texas Medical Center as a core resource, the largest medical center in the world with more than 52 institutions and 92,000 employees. Partners have been instrumental in their support of the Texas Medical Center and share values with leading family offices.
• Cancer Prevention and Research Institute of Texas (CPRIT)coreStrategic or Co-development PartnerSpindletop leverages the $6B CPRIT program as part of their proprietary Texas resources. Dr. Melrose has been instrumental in healthcare and life science across the State of Texas and serves on the selection committee.
• UT M.D. Anderson Cancer CentercoreStrategic or Co-development PartnerOne of the nation's premier cancer centers leveraged for deal flow, clinical expertise, and operational support. The firm has strong connections to MD Anderson through advisory board members like Dr. Gordon Mills.
• San Antonio Military Medical CenterminorStrategic or Co-development PartnerThe largest military hospital in the U.S. Department of Defense is part of Spindletop's proprietary Texas resources for healthcare innovation.
• Aspen InstitutecoreStrategic or Co-development PartnerSpindletop is donating 10% of GP profits from Fund III to support the Aspen Institute and other non-profits focused on addressing racial disparity and healthcare inequality. Multiple team members are Aspen Health Innovator Fellows.
• B Labs / B Impact AssessmentminorOthersSpindletop intends to use the B Labs B Impact Assessment or similar tools to measure the portfolio's progress, incorporating DEI, ESG, and Stakeholder Capitalism measures.
• NASAminorStrategic or Co-development PartnerPart of Spindletop's proprietary Texas resources for healthcare innovation and cross-industry applications.
• Institutional Limited Partner Association (ILPA)coreStrategic or Co-development PartnerSpindletop Capital endorses and follows ILPA Private Equity Principles. They built the foundation of their business on ILPA guidance from the largest institutional investors, endowments, family offices and foundations.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Cressey & Company: Healthcare-focused growth equity firm investing in profitable, lower middle-market healthcare companies. Closely comparable by stage focus, sector specialization, and target company profile.
• HealthQuest Capital: Healthcare-focused growth equity firm investing in commercial-stage healthcare companies, with similar mid-market expansion capital strategy and sector specialization. Directly comparable by strategy, stage focus, and target company profile.
• Linden Capital Partners: Healthcare-dedicated middle-market private equity firm focused on profitable, commercial-stage healthcare companies. Comparable by healthcare-only mandate, growth equity orientation, and lower middle-market deal size.
• Frazier Healthcare Partners: Long-standing healthcare-focused PE firm investing across the lifecycle of healthcare companies including growth equity. Comparable by sector specialization and growth-stage orientation.
• Welsh, Carson, Anderson & Stowe: Healthcare-specialized PE firm with deep domain expertise and expansion-stage investment focus. Comparable by healthcare-only mandate and growth equity strategy, though operating at materially larger fund scale.
• Ampersand Capital Partners: Healthcare and life sciences-focused private equity firm investing in commercial-stage companies. Comparable by healthcare specialization and growth equity approach, with similar middle-market deal sizes.
• Avista Capital Partners: Healthcare-focused private equity firm targeting middle-market growth equity investments. Comparable by sector focus and growth-stage investment strategy, though larger fund scale.
• New Mountain Capital: Growth-oriented investment firm with a significant healthcare services and healthcare technology practice. Comparable by growth-stage mandate and healthcare commercial-stage focus, operating at larger scale.

Broad incumbents

• TPG Capital (Healthcare): Mega-cap private equity firm with a dedicated healthcare practice investing across stages and sub-sectors. Comparable by healthcare growth equity activity but operates at much larger fund scale with broader sector portfolio.
• KKR Health Care Strategic Growth: Major global PE firm with a dedicated healthcare growth strategy targeting commercial-stage healthcare companies. Comparable by stage and sector focus, though operates with substantially larger capital base and team.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/spindletop_scm
• Facebookfacebook.com/spindletopcapital
• LinkedInlinkedin.com/company/spindletop-capital

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments5 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Spindletop Capital Management